Huapont Life Sciences Co., Ltd.
|
14.14 Billion CNY
|
99.39%
|
Zhejiang Hisoar Pharmaceutical Co., Ltd.
|
1.91 Billion CNY
|
95.502%
|
Shandong Wohua Pharmaceutical Co., Ltd.
|
293.3 Million CNY
|
70.582%
|
Kunming Longjin Pharmaceutical Co., Ltd.
|
90.5 Million CNY
|
4.666%
|
Anhui Huangshan Capsule Co., Ltd.
|
171.87 Million CNY
|
49.798%
|
Shanxi Zhendong Pharmaceutical Co.,Ltd
|
1.03 Billion CNY
|
91.674%
|
Beijing Science Sun Pharmaceutical Co., Ltd.
|
154.61 Million CNY
|
44.192%
|
Wuhan Hiteck Biological Pharma Co.,Ltd
|
475.73 Million CNY
|
81.863%
|
Dong-E-E-Jiao Co.,Ltd.
|
2.56 Billion CNY
|
96.637%
|
Zhejiang Garden Bio-chemical High-tech Co., Ltd.
|
2.36 Billion CNY
|
96.355%
|
Fujian Cosunter Pharmaceutical Co., Ltd.
|
1.04 Billion CNY
|
91.745%
|
Shenzhen Neptunus Bioengineering Co., Ltd.
|
28.08 Billion CNY
|
99.693%
|
Livzon Pharmaceutical Group Inc.
|
10 Billion CNY
|
99.138%
|
Hainan Haiyao Co., Ltd.
|
5.16 Billion CNY
|
98.33%
|
Tus-Pharmaceutical Group Co., Ltd.
|
380.47 Million CNY
|
77.322%
|
Jilin Aodong Pharmaceutical Group Co., Ltd.
|
4.76 Billion CNY
|
98.19%
|
Changchun High-Tech Industries (Group) Inc.
|
5.59 Billion CNY
|
98.457%
|
Apeloa Pharmaceutical Co.,Ltd
|
6.5 Billion CNY
|
98.674%
|
Shandong Xinhua Pharmaceutical Company Limited
|
3.45 Billion CNY
|
97.505%
|
PKU HealthCare Corp.,Ltd.
|
1.01 Billion CNY
|
91.515%
|
Chengdu Huasun Technology Group Inc., Ltd.
|
1.05 Billion CNY
|
91.837%
|
Jinling Pharmaceutical Company Limited
|
865.57 Million CNY
|
90.032%
|
Jiuzhitang Co., Ltd.
|
1.34 Billion CNY
|
93.571%
|
Zhejiang Jingxin Pharmaceutical Co., Ltd.
|
2.17 Billion CNY
|
96.038%
|
Hengkang Medical Group Co., Ltd.
|
3.84 Billion CNY
|
97.755%
|
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
|
1.93 Billion CNY
|
95.536%
|
Jinghua Pharmaceutical Group Co., Ltd.
|
369.99 Million CNY
|
76.68%
|
Qianjiang Yongan Pharmaceutical Co., Ltd.
|
290.34 Million CNY
|
70.282%
|
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
|
7.18 Billion CNY
|
98.799%
|
LanZhou Foci Pharmaceutical Co.,Ltd.
|
759.67 Million CNY
|
88.642%
|
Jinhe Biotechnology CO., LTD.
|
2.93 Billion CNY
|
97.062%
|
Teyi Pharmaceutical Group Co.,Ltd
|
481.18 Million CNY
|
82.068%
|
Beijing Aosaikang Pharmaceutical Co., Ltd.
|
513.19 Million CNY
|
83.187%
|
Chengdu Kanghong Pharmaceutical Group Co., Ltd
|
717.76 Million CNY
|
87.979%
|
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
|
573.76 Million CNY
|
84.961%
|
Zhuhai Rundu Pharmaceutical Co., Ltd.
|
1.04 Billion CNY
|
91.772%
|
Tianjin Ringpu Bio-Technology Co.,Ltd.
|
1.79 Billion CNY
|
95.182%
|
Fuan Pharmaceutical (Group) Co., Ltd.
|
1.82 Billion CNY
|
95.278%
|
Hybio Pharmaceutical Co., Ltd.
|
2.49 Billion CNY
|
96.54%
|
Baotou Dongbao Bio-Tech Co.,Ltd
|
848.81 Million CNY
|
89.835%
|
Hunan Er-Kang Pharmaceutical Co., Ltd
|
650.66 Million CNY
|
86.739%
|
Changjiang Pharmaceutical Group Co., Ltd.
|
2.42 Billion CNY
|
96.447%
|
Dezhan Healthcare Company Limited
|
137.14 Million CNY
|
37.085%
|
Hainan Poly Pharm. Co., Ltd
|
3.38 Billion CNY
|
97.448%
|
Jiangxi Synergy Pharmaceutical Co., Ltd.
|
994.99 Million CNY
|
91.328%
|
Zhejiang Tianyu Pharmaceutical Co., Ltd.
|
2.85 Billion CNY
|
96.973%
|
PharmaBlock Sciences (Nanjing), Inc.
|
2.21 Billion CNY
|
96.112%
|
Guangdong Lifestrong Pharmacy Co., Ltd.
|
77.33 Million CNY
|
-11.58%
|
Anhui Fengyuan Pharmaceutical Co., Ltd.
|
2.47 Billion CNY
|
96.51%
|
Huaren Pharmaceutical Co., Ltd.
|
2.39 Billion CNY
|
96.404%
|
Betta Pharmaceuticals Co., Ltd.
|
3.65 Billion CNY
|
97.637%
|
Tibet AIM Pharm. Inc.
|
177.68 Million CNY
|
51.439%
|
Shenzhen Kangtai Biological Products Co., Ltd.
|
5.21 Billion CNY
|
98.345%
|
Shandong Shanda Wit Science and Technology Co., Ltd.
|
623.79 Million CNY
|
86.168%
|
Pacific Shuanglin Bio-pharmacy Co., LTD
|
1.2 Billion CNY
|
92.861%
|
Zhejiang AngLiKang Pharmaceutical CO.,LTD.
|
1.18 Billion CNY
|
92.735%
|
Xiamen Kingdomway Group Company
|
1.41 Billion CNY
|
93.91%
|
ShanXi C&Y Pharmaceutical Group Co., Ltd.
|
654.64 Million CNY
|
86.82%
|
Walvax Biotechnology Co., Ltd.
|
3.77 Billion CNY
|
97.711%
|
Sunflower Pharmaceutical Group Co.,Ltd
|
1.53 Billion CNY
|
94.379%
|
Harbin Gloria Pharmaceuticals Co., Ltd
|
1.42 Billion CNY
|
93.942%
|
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
|
15.42 Billion CNY
|
99.44%
|
Hunan Hansen Pharmaceutical Co., Ltd.
|
356.64 Million CNY
|
75.807%
|
Changzhou Qianhong Biopharma CO.,LTD
|
210.32 Million CNY
|
58.976%
|
Shenzhen Weiguang Biological Products Co., Ltd.
|
831.13 Million CNY
|
89.618%
|
Honz Pharmaceutical Co., Ltd.
|
787.6 Million CNY
|
89.045%
|
Northeast Pharmaceutical Group Co., Ltd.
|
9.95 Billion CNY
|
99.133%
|
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
|
2.13 Billion CNY
|
95.964%
|
Guizhou Xinbang Pharmaceutical Co., Ltd.
|
2.08 Billion CNY
|
95.853%
|
Tianjin Lisheng Pharmaceutical Co.,Ltd.
|
849.24 Million CNY
|
89.84%
|
Zhejiang Yatai Pharmaceutical Co., Ltd.
|
848.49 Million CNY
|
89.831%
|
Zhejiang NHU Company Ltd.
|
14.23 Billion CNY
|
99.394%
|
ApicHope Pharmaceutical Co., Ltd
|
1.8 Billion CNY
|
95.226%
|
Shanghai Kaibao Pharmaceutical CO.,Ltd
|
546.81 Million CNY
|
84.22%
|
Beijing SL Pharmaceutical Co., Ltd.
|
420.68 Million CNY
|
79.489%
|
Yunnan Baiyao Group Co.,Ltd
|
13.64 Billion CNY
|
99.367%
|
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD
|
625.14 Million CNY
|
86.198%
|
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
|
607.46 Million CNY
|
85.796%
|
Huadong Medicine Co., Ltd
|
11.75 Billion CNY
|
99.266%
|
Jiangsu Nhwa Pharmaceutical Co., LTD
|
864.22 Million CNY
|
90.016%
|
Harbin Medisan Pharmaceutical Co., Ltd.
|
1.29 Billion CNY
|
93.336%
|
Tianjin Chase Sun Pharmaceutical Co.,Ltd
|
2.96 Billion CNY
|
97.092%
|
Beijing Beilu Pharmaceutical Co., Ltd
|
1.03 Billion CNY
|
91.648%
|
Nanjing Hicin Pharmaceutical Co., Ltd.
|
424.92 Million CNY
|
79.694%
|
Renhe Pharmacy Co., Ltd.
|
752.88 Million CNY
|
88.539%
|
Chongqing Pharscin Pharmaceutical Co., Ltd.
|
233.53 Million CNY
|
63.052%
|
Zhejiang Xianju Pharmaceutical Co.,Ltd.
|
1.1 Billion CNY
|
92.191%
|
Luoxin Pharmaceuticals Group Stock Co., Ltd.
|
2.45 Billion CNY
|
96.485%
|
Guizhou Bailing Group Pharmaceutical Co., Ltd.
|
3.82 Billion CNY
|
97.742%
|